Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion type Assertion NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_head.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion wasGeneratedBy ECO_0000203 NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion wasDerivedFrom befree-20150227 NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion SIO_000772 24011769 NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion evidence source_evidence_literature NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.
- NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor α (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.